Value of (18)F-FDG-PET to predict PD-L1 expression and outcomes of PD-1 inhibition therapy in human cancers

Anti-programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1) antibodies are administered in varied human cancer types. The expression of PD-L1 within tumor cells has been identified as a predictive marker, although assessing its expression has benefitted only patients with non-small cell lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaira, Kyoichi, Kuji, Ichiei, Kagamu, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805193/
https://www.ncbi.nlm.nih.gov/pubmed/33441183
http://dx.doi.org/10.1186/s40644-021-00381-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805193/
https://www.ncbi.nlm.nih.gov/pubmed/33441183
http://dx.doi.org/10.1186/s40644-021-00381-y

Ejemplares similares